Replies to post #266497 on Bioelectronics Corp (BIEL)

[pinhigh]

Thanks srin....Biel's Actipatch is such a unique product...in that it holds "Standard of Care" potential. Talk about the poeential for increased "Buying Volume"! Just wait! Biel product is just being discovered by society. Biel's powerful new OEM partners are definitely bringing it!

[ddls]

Simple, investors are staying away from this for many reasons, here's just a couple:

Investors are waiting for the next Q results, and if they seriously increase sales or not. I'm sure Kelly will "pre announce" if they are good (but how good).

too many shares, too many noteholders, many due in this years second half.

Many pink investors don't think BIEL can sustain sales, I agree.

Many investors aren't impressed with the volatility (classic pink flipper) and the current management (the family run scam). We all know how this share structure is abused.

The lack of reporting on time (except for Q1) on a consistent basis.
Plus the OTC Yield signs on a consistent basis.

Many investors see this as a dead sector, which it is. BIEL is too late with too little for the game.

If BIEL can't even finish in the top 10 at the FDA Opioid Challenge why would the professional investor care about this junk?

I could list more, but you should get the picture

Declining Sales Cheers!